Literature DB >> 26816913

Metronidazole-Induced Bullous Pemphigoid: A Case Report.

Saibal Moitra1, Sukanta Sen2, Indranil Banerjee3, Ayan Sikder4, Prasanta Das5.   

Abstract

Bullous pemphigoid is an autoimmune cutaneous blistering disorder, the exact pathogenesis of which is still not fully elucidated. Drug-induced bullous pemphigoid eruptions are rare but have been reported earlier with the use of frusemide, psoralens, ibuprofen, galantamine hydrobromide, ACE inhibitors like captopril, spironolactone, penicillin, ampicillin, levofloxacin, penicillamine. We hereby report a case of metronidazole induced bullous pemphigoid (BP) in a 52-year-old male patient suffering from liver abscess following 4 days of drug administration. The skin biopsy findings obtained from the patient were consistent with the diagnosis of bullous pemphigoid (BP). Metronidazole was discontinued and symptomatic treatment was offered to the patient. Following withdrawal of metronidazole, the bullae subsided in the next 7-10 days without any significant residual scarring. The causality assessment performed as per the Naranjo algorithm revealed the case to be probable (Naranjo score 7).

Entities:  

Keywords:  Adverse drug reaction; Cutaneous drug eruptions; Drug-induced bullous pemphigoid

Year:  2015        PMID: 26816913      PMCID: PMC4717712          DOI: 10.7860/JCDR/2015/14669.6972

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  12 in total

1.  Comment: hospital admissions resulting from preventable adverse drug reactions.

Authors:  Phyllis M Lau; Kay Stewart; Michael J Dooley
Journal:  Ann Pharmacother       Date:  2003-02       Impact factor: 3.154

2.  Preventability and severity assessment in reporting adverse drug reactions.

Authors:  S C Hartwig; J Siegel; P J Schneider
Journal:  Am J Hosp Pharm       Date:  1992-09

3.  Severe bullous fixed drug eruption due to metronidazole mimicking a localized form of toxic epidermal necrolysis.

Authors:  P Bhargava; D K Mathur; U S Agarwal; R Bhargava
Journal:  Indian J Dermatol Venereol Leprol       Date:  1996 Jan-Feb       Impact factor: 2.545

4.  Bullous pemphigoid precipitated by galantamine hydrobromide.

Authors:  Mohammad Diab; Jacquelyn Coloe; Mark A Bechtel
Journal:  Cutis       Date:  2009-03

5.  Bullous fixed drug eruption (BFDE) following per-oral metronidazole.

Authors:  V N Sehgal; S Khandpur; K Sardana; P Bajaj
Journal:  J Eur Acad Dermatol Venereol       Date:  2003-09       Impact factor: 6.166

6.  Efalizumab-induced bullous pemphigoid.

Authors:  Tu Anh Duong; Valérie Buffard; Chantal André; Nicolas Ortonne; Jean Revuz; Martine Bagot; Jean-Claude Roujeau
Journal:  J Am Acad Dermatol       Date:  2010-01       Impact factor: 11.527

7.  A case of levetiracetam induced bullous pemphigoid.

Authors:  Ayse Serap Karadag; Serap Gunes Bilgili; Omer Calka; Sevda Onder; Mustafa Kosem; Evren Burakgazi-Dalkilic
Journal:  Cutan Ocul Toxicol       Date:  2012-10-03       Impact factor: 1.820

8.  Case of drug-induced bullous pemphigoid by levofloxacin.

Authors:  Hui-Jun Ma; Rong Hu; Chi-Yu Jia; Yang Yang; Lian-Jin Song
Journal:  J Dermatol       Date:  2012-08-20       Impact factor: 4.005

9.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

10.  Dipeptidyl peptidase-4 inhibitors cause bullous pemphigoid in diabetic patients: report of two cases.

Authors:  Efi Pasmatzi; Alexandra Monastirli; John Habeos; Sophia Georgiou; Dionysios Tsambaos
Journal:  Diabetes Care       Date:  2011-08       Impact factor: 19.112

View more
  2 in total

1.  A Systematic Review of Drug-Induced Pemphigoid.

Authors:  Matthew J Verheyden; Asli Bilgic; Dédée F Murrell
Journal:  Acta Derm Venereol       Date:  2020-08-17       Impact factor: 3.875

Review 2.  Bullous Pemphigoid: Trigger and Predisposing Factors.

Authors:  Francesco Moro; Luca Fania; Jo Linda Maria Sinagra; Adele Salemme; Giovanni Di Zenzo
Journal:  Biomolecules       Date:  2020-10-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.